Skip to content

Revogene Strep A 410400

by Meridian Bioscience Inc.

Revogene Strep A 410400 is a Class II device made by Meridian Bioscience Inc., listed in FDA GUDID since 15 Jul 2020 (UDI-DI 00840733102325), registry data as of 8 Nov 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00840733102325 UDI-DI Date15 Jul 2020ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Revogene Strep A
Generic name
Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / reference
410400
Primary DI / UDI-DI
00840733102325
FDA product code
PGX, OOI
GMDN term
Beta-haemolytic Group A Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class II
Regulation number
866.2680, 862.2570
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code PGX (Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System).

Other devices from Meridian Bioscience Inc.

See all devices from Meridian Bioscience Inc. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)